Eleanor McFadden
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Surgery top 1%
- Public Health, Environmental and Occupational Health top 1%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Douglass C. TormeyPaul P. CarboneMartin M. OkenJohn HortonThomas E. DavisRichard H. CreechLuca GianniDavid Cameron
- Topics
- Economic and Financial Impacts of Cancer (3 papers)Health Systems, Economic Evaluations, Quality of Life (2 papers)Breast Cancer Treatment Studies (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Eleanor McFadden
13 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 5.0k
- Pulmonary and Respiratory Medicine 3.2k
- Surgery 2.1k
- Public Health, Environmental and Occupational Health 1.2k
- Pathology and Forensic Medicine 1.1k
Countries citing papers authored by Eleanor McFadden
This map shows the geographic impact of Eleanor McFadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleanor McFadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleanor McFadden more than expected).
Fields of papers citing papers by Eleanor McFadden
This network shows the impact of papers produced by Eleanor McFadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleanor McFadden. The network helps show where Eleanor McFadden may publish in the future.
Co-authorship network of co-authors of Eleanor McFadden
This figure shows the co-authorship network connecting the top 25 collaborators of Eleanor McFadden. A scholar is included among the top collaborators of Eleanor McFadden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleanor McFadden. Eleanor McFadden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trialbreakdown → | 688 |
| 2 | 16 | |
| 3 | 8 | |
| 4 | 214 | |
| 5 | 22 | |
| 6 | 16 | |
| 7 | 26 | |
| 8 | 1 | |
| 9 | 49 | |
| 10 | 37 | |
| 11 | 155 | |
| 12 | Toxicity and response criteria of the Eastern Cooperative Oncology Groupbreakdown → | 8854 |
| 13 | 37 |
About Eleanor McFadden
Eleanor McFadden is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 13 papers that have together received 10.1k indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (5.0k citations), Geriatrics and Gerontology (455 citations) and Pulmonary and Respiratory Medicine (3.2k citations). Eleanor McFadden has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Douglass C. Tormey, Paul P. Carbone, Martin M. Oken, John Horton, Thomas E. Davis, Richard H. Creech, Luca Gianni, David Cameron, Evandro de Azambuja and N. Al-Sakaff. Their work appears in journals such as New England Journal of Medicine, The Lancet and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.